IDiyas

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 8865754 B1

PDFFull Text
Date of Patent:
Oct. 21, 2014

Filed:

Mar. 01, 2012

Compounds for the treatment of neurodegenerative diseases

Applicants:

Luke A. Esposito, Seattle, WA (US);

Marisa C. Yadon, Seattle, WA (US);

Joel Cummings, Seattle, WA (US);

F. Michael Hudson, Oakland, CA (US);

Thomas Lake, Snohomish, WA (US);

Franz F. Hefti, Bernardsville, NJ (US);

Geoffrey Golding, Philadelphia, PA (US);

Seok-rye Choi, Aston, PA (US);

Ximin LI, Ardmore, PA (US);

Alan D. Snow, Lynnwood, WA (US);

Qubai HU, Kirkland, WA (US);

Judy Cam, Bellevue, WA (US);

Inventors:

Luke A. Esposito, Seattle, WA (US);

Marisa C. Yadon, Seattle, WA (US);

Joel Cummings, Seattle, WA (US);

F. Michael Hudson, Oakland, CA (US);

Thomas Lake, Snohomish, WA (US);

Franz F. Hefti, Bernardsville, NJ (US);

Geoffrey Golding, Philadelphia, PA (US);

Seok-Rye Choi, Aston, PA (US);

Ximin Li, Ardmore, PA (US);

Alan D. Snow, Lynnwood, WA (US);

Qubai Hu, Kirkland, WA (US);

Judy Cam, Bellevue, WA (US);

Assignee:

Proteotech Inc., Kirkland, WA (US);

Attorney:

Rebecca Eagen

Primary Examiner:

Alicia L Otton

Int. Cl.
CPC ...
C07D 263/32 (2006.01); C07D 277/32 (2006.01); C07D 333/16 (2006.01); C07D 285/12 (2006.01); C07D 263/56 (2006.01); C07D 271/107 (2006.01); C07C 205/22 (2006.01); C07D 263/57 (2006.01); C07C 255/53 (2006.01); C07D 249/06 (2006.01); C07C 235/56 (2006.01); C07D 277/24 (2006.01); C07D 271/10 (2006.01); C07D 333/28 (2006.01); C07C 205/20 (2006.01); C07D 409/14 (2006.01); C07D 285/08 (2006.01); A61J 1/00 (2006.01); C07D 231/06 (2006.01);
U.S. Cl.
CPC ...
C07D 263/32 (2013.01); C07D 277/32 (2013.01); C07D 333/16 (2013.01); C07D 285/12 (2013.01); C07D 263/56 (2013.01); C07D 271/107 (2013.01); C07C 205/22 (2013.01); C07D 263/57 (2013.01); C07C 255/53 (2013.01); C07D 249/06 (2013.01); C07C 235/56 (2013.01); C07D 277/24 (2013.01); C07D 271/10 (2013.01); C07D 333/28 (2013.01); C07C 205/20 (2013.01); C07D 409/14 (2013.01); C07D 285/08 (2013.01); A61J 1/00 (2013.01); C07D 231/06 (2013.01);
Abstract

Compounds and their pharmaceutically acceptable salts for treatment of synucleinopathies, such as Parkinson's disease and tauopathies.

Find Patent Forward Citations

Loading…